BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//REMEDi4ALL - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:REMEDi4ALL
X-ORIGINAL-URL:https://remedi4all.org
X-WR-CALDESC:Events for REMEDi4ALL
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Amsterdam
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20220327T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20221030T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20230326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20231029T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20241027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20261025T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/London
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20241027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20261025T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/Halifax
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20230312T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20231105T050000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20240310T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20241103T050000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20250309T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20251102T050000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Asia/Tokyo
BEGIN:STANDARD
TZOFFSETFROM:+0900
TZOFFSETTO:+0900
TZNAME:JST
DTSTART:20220101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/Amsterdam:20251127T130000
DTEND;TZID=Europe/Amsterdam:20251127T140000
DTSTAMP:20260422T021511
CREATED:20251113T085710Z
LAST-MODIFIED:20251127T103945Z
UID:16671-1764248400-1764252000@remedi4all.org
SUMMARY:ProvenConnect REMEDi4ALL Webinar
DESCRIPTION:* This is an online event that will take place 1200–1300 UK time (1300-1400 CET) on Zoom. * \nREMEDi4ALL is presenting to the TAR Network in a Proven Connect webinar. Speakers Alicia Soler (Lead Scientific Operations at REMEDi4ALL /EATRIS)\, Heleen van der Meer (Senior programme manager international drug repurposing at ZonMw) and Pan Pantziarka (Director of Drug Repurposing at Anticancer Fund) will present the REMEDi4ALL project and Funder’s Network.
URL:https://remedi4all.org/event/provenconnect-remedi4all-webinar/
LOCATION:Online Event
ATTACH;FMTTYPE=image/png:https://remedi4all.org/wp-content/uploads/2025/11/REMEDi4ALL-funders-network-Post-para-LinkedIn-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Amsterdam:20251121T140000
DTEND;TZID=Europe/Amsterdam:20251121T153000
DTSTAMP:20260422T021511
CREATED:20250915T161006Z
LAST-MODIFIED:20250915T161006Z
UID:15186-1763733600-1763739000@remedi4all.org
SUMMARY:Webinar: IP Strategies for Repurposing
DESCRIPTION:Discover the value of having an intellectual property (IP) strategy in your repurposing project and how to use this to drive success! \nNot sure where to start with intellectual property (IP) in your drug repurposing project? REMEDi4ALL’s Repurposing Academy is here to guide you! \nJoin us for our upcoming webinar where we will explore the importance of considering IP as part of your broader drug repurposing strategy. \nWe’ll discuss common challenges you may encounter and key considerations to keep in mind throughout your repurposing project. Additionally\, we’ll outline practical steps for securing IP protection for repurposed drugs and show how a strong IP strategy can help drive your project forward.
URL:https://remedi4all.org/event/webinar-ip-for-repurposing/
LOCATION:Online Event
ATTACH;FMTTYPE=image/png:https://remedi4all.org/wp-content/uploads/2025/09/CT-Webinar-Series-Webinar-1-FINAL.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Amsterdam:20251006T140000
DTEND;TZID=Europe/Amsterdam:20251010T170000
DTSTAMP:20260422T021511
CREATED:20250415T104016Z
LAST-MODIFIED:20250811T092029Z
UID:11711-1759759200-1760115600@remedi4all.org
SUMMARY:2025 REMEDi4ALL Hackathon
DESCRIPTION:Are you an early career researcher (ECR) who wants to delve into drug repurposing?\n  \nJoin us for the second REMEDi4ALL Hackathon\, 6-10 October 2025\, held at Hotel Checkin Montserrat\, near Barcelona\, Spain. \nThe REMEDi4ALL Repurposing Hackathon is designed to help early career researchers learn by doing. Join a small team of international trainees keen to learn about the repurposing pathway on a week-long residential course where you aim to plan the development of a repurposing candidate for a specific patient community.  \nWho is the Hackathon for?\n\nStudents and researchers in the early stages of their career up to 2 years post-doc\nIndividuals with an interest in drug repurposing\nIndividuals with an excellent scientific track record\nPrevious experience in the drug repurposing field will be considered a plus\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nWhat will you learn?\nThe REMEDi4ALL Hackathon aims to teach participants how to: \n\nUse computational tools to generate repurposing candidates suitable for a defined indication\nNarrow down potential repurposed drug options tailored to a particular indication\nIdentify needs and knowledge gaps in a repurposing project\, helping to define the path for a drug candidate\nWork together with other ECRs to complete a repurposing challenge\n\n\n  \n\nTraining format\n\n\n\nIn-person\, residential training for 15 participants\nAdvance registration required\nSmall teams of early career researchers work on a project throughout the week\nSupport through lectures and guidance of REMEDi4ALL experts\, and external advisers\, including patient experts\n\n\n\n\n\n  \nInterested in learning more? Check out our highlights video from 2024 or explore the Hackathon website within the REMEDi4ALL Repurposing Academy.
URL:https://remedi4all.org/event/2025-remedi4all-hackathon/
LOCATION:Hotel Checkin Montserrat\, Carrer Querol\, 08293 Collbató\, Barcelona\, Spain
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Amsterdam:20250731T163000
DTEND;TZID=Europe/Amsterdam:20250731T173000
DTSTAMP:20260422T021511
CREATED:20250721T084522Z
LAST-MODIFIED:20250721T084539Z
UID:14110-1753979400-1753983000@remedi4all.org
SUMMARY:Webinar: Cures Within Reach new funding call: Clinical trials to validate AI-driven drug repurposing
DESCRIPTION:Artificial intelligence (AI) is increasingly seen as a powerful tool in the search for new treatments – especially through drug repurposing. By analysing large sets of data\, AI can help identify existing medicines that might work for different conditions – something particularly valuable in rare diseases. \nHowever\, do AI-generated predictions actually work when tested in real-life clinical trials? \nCures Within Reach is helping to explore this question through a new funding call. They’re inviting letters of intent for Phase I/IIA clinical trials that will test and validate AI-based repurposing ideas\, with a preference for rare disease. \nLearn more about the call here. \n\n\n\n\nThis webinar hosted by Beacon for Rare Diseases in collaboration with REMEDi4ALL and Cures within Reach will cover: \n\nA breakdown of what this funding call is about\nAdvice from Cures Within Reach on what makes a strong application\nHow patient groups can get involved in applications\nA practical example of a patient group contributing to an AI-led initiative\nThe opportunity to ask any questions you might have to the Cures Within Reach team\n\n\n\n\nRegister for the webinar here!
URL:https://remedi4all.org/event/cures-within-reach-new-funding-call-clinical-trials-to-validate-ai-driven-drug-repurposing/
LOCATION:Online Event
ATTACH;FMTTYPE=image/png:https://remedi4all.org/wp-content/uploads/2025/07/Image20250718102044-scaled.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Amsterdam:20250611T190000
DTEND;TZID=Europe/Amsterdam:20250611T203000
DTSTAMP:20260422T021511
CREATED:20250512T110903Z
LAST-MODIFIED:20250512T110903Z
UID:12334-1749668400-1749673800@remedi4all.org
SUMMARY:Recurrent Respiratory Papillomatosis (RRP) Awareness Day Webcast
DESCRIPTION:RRP Awareness Day is an international event to raise awareness about recurrent respiratory papillomatosis (RRP)\, a debilitating disease driven by chronic HPV 6/11 viral infection.\nJoin the RRP Awareness Day global webcast on June 11th to hear from RRP patients\, their caregivers\, and the healthcare community supporting them about:\n\n\n\n\n\nPatient and caregiver experience with RRP\nSignificant burden of living with RRP\nChallenges of repeated surgeries and risk of irreversible injury\nNeed for new innovations\n\nCO-HOSTS\n\n\nRRP Foundation\nKim McClellan\, President \n\n\n\n\nPRECIGEN\nHelen Sabzevari\, PhD\, President and CEO \n\n\n\nWho should attend?\n\n\n\n\n\n\nRRP patients\nCaregivers and family members\nHealthcare providers\nCommunity supporting RRP patients
URL:https://remedi4all.org/event/recurrent-respiratory-papillomatosis-rrp-awareness-day-webcast/
LOCATION:Online Event
ATTACH;FMTTYPE=image/png:https://remedi4all.org/wp-content/uploads/2025/05/mnt7l7APQUyc2_HJmrdS_Q.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20250507
DTEND;VALUE=DATE:20250509
DTSTAMP:20260422T021511
CREATED:20241007T132248Z
LAST-MODIFIED:20241209T151356Z
UID:8550-1746576000-1746748799@remedi4all.org
SUMMARY:International Drug Repurposing Conference 2025 - #iDR25
DESCRIPTION:Exciting news for anyone passionate about healthcare innovation—iDR25\, the International Drug Repurposing Conference\, is coming up on 7-8th May 2025 in the beautiful city of Amsterdam in The Netherlands!
URL:https://remedi4all.org/event/international-drug-repurposing-conference-2025-idr25/
LOCATION:Amsterdam\, the Netherlands
ATTACH;FMTTYPE=image/png:https://remedi4all.org/wp-content/uploads/2024/09/iDR25-Branding-SoMe-Card.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Amsterdam:20250506T120000
DTEND;TZID=Europe/Amsterdam:20250506T183000
DTSTAMP:20260422T021511
CREATED:20241115T092618Z
LAST-MODIFIED:20250414T104630Z
UID:8873-1746532800-1746556200@remedi4all.org
SUMMARY:#iDR25 Pre-Conference Workshops
DESCRIPTION:To kick off the iDR25 conference series\, two exclusive pre-conference workshops will be held on 6th May 2025 at the Royal Netherlands Academy of Arts and Sciences (KNAW). The workshops are primarily aimed at academics\, early career researchers and patient representatives looking to increase the understanding of key topics related to medicines repurposing and gain practical skills to apply to current and future drug repurposing projects. \nRegister today for the pre-iDR25 workshop series!\n  \nWorkshop 1: Health Technology Assessment: a key tool to patient access\nTuesday 6th May 2025\n12:30-14:30\n  \n \nAfter regulatory approval by the EMA\, Health Technology Assessment (HTA) becomes a pivotal process in determining whether new treatments will be accessible to patients\, influencing their affordability\, availability\, and overall impact on healthcare systems. The HTA dossier encapsulates critical information\, including the medical\, economic\, social\, and ethical considerations of using a health technology—such as a repurposed medicine. Prepared by the product developer or sponsor\, these dossiers undergo evaluation by HTA agencies\, like EUnetHTA 21 in the EU or NICE in the UK\, to assess their value and feasibility. \nThis workshop  will equip researchers\, patient representatives and product developers with the knowledge and tools to design their repurposing projects to meet HTA standards from the onset. With a focus on early alignment with HTA requirements\, evidence planning\, and incorporating patient engagement into the HTA process from the beginning\, attendees will gain actionable insights to streamline their projects through HTA evaluations\, enhancing the likelihood of timely patient access. \nThis workshop offers a unique opportunity to learn proactive strategies to maximise the success of drug repurposing projects in achieving their ultimate goal—reaching and benefiting patients. \n  \n[team_member description=”” social=”” link_element=”both” color=”accent-color” image_url=”https://remedi4all.org/wp-content/uploads/2024/11/Dalma-Hosszu.png” name=”Dalma Hosszú” job_position=”Syreon Research Institute” link_url=”https://remedi4all.org/people/idr-speaker/dalma-hosszu/”]\n [team_member description=”” social=”” link_element=”both” color=”accent-color” image_url=”https://remedi4all.org/wp-content/uploads/2024/11/Andras-Perenyi.png” name=”András Perényi” job_position=”Syreon Research Institute” link_url=”https://remedi4all.org/people/idr-speaker/andras-perenyi/”]\n \n \n \n \n  \nWorkshop 2: Navigating the regulatory path for medicinal product repurposing\nTuesday 6th May 2025\n15:00-18:30\n  \n \nIn this workshop\, we will discuss the regulatory path and key milestones for advancing a repurposed/repositioned medicinal product from preclinical development to market authorisation in Europe\, tailored for academic researchers and early-career developers navigating such processes for the first time. Whether you are preparing for your first clinical trial application or strategising for market authorisation\, this session will provide crucial tools and insights to help build your regulatory strategy including: \n\nCore elements of a Clinical Trial Application (CTA)\nObtaining Orphan Drug Designations for rare diseases\nEffective engagement with regulatory authorities (e.g. scientific advice)\nOverview of possible registration pathways to bring promising therapies to patients faster\nBuilding the Common Technical Document (CTD) for a European Marketing Authorisation Application (MAA)\n\nConfirmed speakers \n [team_member description=”” social=”” link_element=”both” color=”accent-color” image_url=”https://remedi4all.org/wp-content/uploads/2024/11/Violeta-_Workshop.png” name=”Violeta Stoyanova-Beninska” job_position=”Human Division of the European Medicines Agency (EMA)” link_url=”https://remedi4all.org/people/idr-speaker/violeta-stoyanova-beninska/”]\n [team_member description=”” social=”” link_element=”both” color=”accent-color” image_url=”https://remedi4all.org/wp-content/uploads/2024/11/Rosan-Vegter.png” name=”Rosan Vegter” job_position=”EATRIS” link_url=”https://remedi4all.org/people/idr-speaker/rosan-vegte/”]\n[team_member description=”” social=”” link_element=”both” color=”accent-color” image_url=”https://remedi4all.org/wp-content/uploads/2024/11/Nadina-Grosios.png” name=”Nadina Grosios” job_position=”Oncoknow” link_url=”https://remedi4all.org/people/idr-speaker/nadina-grosios/”] \n \n \nRegister today for the pre-iDR25 workshop series!\n  \nNote: this event is separate to the main conference. Find out more about iDR25: Medicines Reimagined here. \nQuestions? Contact conference@remedi4all.org.
URL:https://remedi4all.org/event/idr25-pre-conference-workshops/
LOCATION:Royal Netherlands Academy of Arts and Sciences (KNAW)\, Het Trippenhuis\, Kloveniersburgwal 29\, 1011 JV\, Amsterdam\, 1011 JV\, Netherlands
ATTACH;FMTTYPE=image/png:https://remedi4all.org/wp-content/uploads/2024/11/iDR25-Workshops-1-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20250506
DTEND;VALUE=DATE:20250507
DTSTAMP:20260422T021511
CREATED:20241112T085350Z
LAST-MODIFIED:20250423T074835Z
UID:8841-1746489600-1746575999@remedi4all.org
SUMMARY:REMEDi4ALL Funders Network Event 2025
DESCRIPTION:Pre-iDR25 REMEDi4ALL Funders Network Event\nIn an exclusive pre-conference meeting\, members and observers of the REMEDi4ALL Funders Network will come together to share best practices and discuss important topics. This meeting will be followed by an evening boat trip on the Amsterdam canals and a Funders Network dinner at IJver restaurant. \nRegister here!\n  \nMeeting location: Royal Netherlands Academy of Arts and Sciences (KNAW)\, Het Trippenhuis\, Kloveniersburgwal 29\, Amsterdam \nDinner location: IJver Restaurant\, Scheepsbouwkade 72\, Amsterdam
URL:https://remedi4all.org/event/2025-remedi4all-funders-network-meeting/
LOCATION:Royal Netherlands Academy of Arts and Sciences (KNAW)\, Het Trippenhuis\, Kloveniersburgwal 29\, 1011 JV\, Amsterdam\, 1011 JV\, Netherlands
ATTACH;FMTTYPE=image/png:https://remedi4all.org/wp-content/uploads/2024/11/iDR25-Workshops-3-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Amsterdam:20250401T120000
DTEND;TZID=Europe/Amsterdam:20250401T133000
DTSTAMP:20260422T021511
CREATED:20250319T090008Z
LAST-MODIFIED:20250319T090008Z
UID:11056-1743508800-1743514200@remedi4all.org
SUMMARY:Unlocking research opportunities: Partnering with academics
DESCRIPTION:Are you looking to engage in research but don’t know where to start?\nResearch is a key priority for many patient groups but connecting with the right academic partners is not often straightforward. With limited awareness of rare conditions in academia\, knowing where to start\, initiating conversations\, and building lasting relationships with the right research teams can be challenging. \nWhat will you learn in this webinar?\n\nHow academic research works and the structures that shape it\nWhere to find researchers working on your condition and how to connect with them\nPractical ways to boost the appeal of your patient group to researchers\nA real-world example of a patient group successfully partnering with academics and getting involved in research\n\n  \nFor more information visit the event page here.
URL:https://remedi4all.org/event/unlocking-research-opportunities-partnering-with-academics/
LOCATION:Online Event
ATTACH;FMTTYPE=image/jpeg:https://remedi4all.org/wp-content/uploads/2025/03/Academics-webinar-graphic-1.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20250317
DTEND;VALUE=DATE:20250319
DTSTAMP:20260422T021511
CREATED:20250122T092332Z
LAST-MODIFIED:20250124T131341Z
UID:9772-1742169600-1742342399@remedi4all.org
SUMMARY:REMEDi4ALL Drug Repurposing Bootcamp for Academics
DESCRIPTION:Drug repurposing offers a faster\, more cost-effective way to develop treatments\, addressing urgent patient needs and unlocking opportunities for academic innovation. However\, the journey from a repurposing concept to a market-ready product is complex\, presenting significant challenges for researchers. The REMEDi4ALL Drug Repurposing Bootcamp for Academics is designed to support senior post-doctoral researchers and early-career principal investigators leading promising projects by equipping them with the skills and knowledge to navigate this pathway successfully. \nThis immersive\, day-and-a-half training programme combines expert lectures\, interactive discussions\, and working groups to cover key topics such as regulatory engagement\, collaboration building\, funding applications\, and science communication. By participating\, attendees will not only develop a clearer understanding of how to deliver real patient impact but also join the growing REMEDi4ALL community. \nTwenty fully funded places are available\, covering travel\, accommodation\, and access to this free training. Applications are open until February\, with reviews conducted on a rolling basis. \nFind out more information here: REMEDi4ALL Drug Repurposing Bootcamp for Academics \nRegister here!
URL:https://remedi4all.org/event/dr-bootcamp-academics-2025/
LOCATION:Hinxton Hall\, Wellcome Genome Campus\, Hinxton\, Cambridge\, CB10 1RQ\, United Kingdom
ATTACH;FMTTYPE=image/png:https://remedi4all.org/wp-content/uploads/2025/01/R4ALL-academic-bootcamp-final-graphic.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Amsterdam:20250307T110000
DTEND;TZID=Europe/Amsterdam:20250307T123000
DTSTAMP:20260422T021511
CREATED:20250124T125052Z
LAST-MODIFIED:20250124T140654Z
UID:9917-1741345200-1741350600@remedi4all.org
SUMMARY:REMEDi4ALL Clinical Trials Webinar Series: Support and Management of Clinical Trials
DESCRIPTION:Register for Webinar 3 here!\n  \nWebinar 3: Support and Management of Clinical Trials – 7 March (11:00-12:30 CET)\nExploring different organisations\, processes and pathways for expert support when planning\, setting up and running a clinical trial.\nIn this third and final webinar in the series we will highlight different collaborations that are required in running a clinical trial efficiently. Find out more here!
URL:https://remedi4all.org/event/remedi4all-clinical-trials-webinar-series-support-management-clinical-trials/
LOCATION:Online Event
ATTACH;FMTTYPE=image/png:https://remedi4all.org/wp-content/uploads/2025/01/CT-Webinar-Series-Webinar-3-FINAL-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Amsterdam:20250228T120000
DTEND;TZID=Europe/Amsterdam:20250228T133000
DTSTAMP:20260422T021511
CREATED:20250220T123719Z
LAST-MODIFIED:20250220T123719Z
UID:10447-1740744000-1740749400@remedi4all.org
SUMMARY:DREAMS Project Webinar - Clinical Trials in Focus: Innovations and Patient Perspectives in Rare Diseases
DESCRIPTION:Join leading experts as they explore advancements in clinical trial methodologies\, outcome measures\, and lessons learned from research in muscular disorders. \nDuring this session\, experts in the field will share insights on: \n• The need for innovation in clinical trial methodologies for muscular disorders. \n• An overview of outcome measures in clinical trials for neuromuscular disorders. \n• Lessons learned from a decade of clinical trials on Duchenne muscular dystrophy (DMD). \nAs part of the event\, a patient will share their personal journey and insights on participating in clinical trials. Following their testimony\, there will be an interactive Q&A session where you can engage directly and ask questions.
URL:https://remedi4all.org/event/dreams-project-webinar-clinical-trials-in-focus-innovations-and-patient-perspectives-in-rare-diseases/
LOCATION:Online Event
ATTACH;FMTTYPE=image/jpeg:https://remedi4all.org/wp-content/uploads/2025/02/1739865406225.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Amsterdam:20250228T110000
DTEND;TZID=Europe/Amsterdam:20250228T123000
DTSTAMP:20260422T021511
CREATED:20250124T124644Z
LAST-MODIFIED:20250124T140332Z
UID:9918-1740740400-1740745800@remedi4all.org
SUMMARY:REMEDi4ALL Clinical Trials Webinar Series: Clinical Trials for Rare Diseases
DESCRIPTION:Register for Webinar 2 here!\n\nWebinar 2: Clinical Trials for Rare Diseases – 28 Feb (11:00-12:30 CET)\nExploring different ways of conducting clinical trials\, particularly for rare disease. \nOur Rare Disease Day special! This webinar will explore different ways of conducting clinical trials in smaller populations where ‘traditional’ methods might not be as appropriate. We will describe what endpoints are and how these can guide trial design in a patient-centric way. We will explore how the patient voice can help inform trial design and outcomes. Find out more here!
URL:https://remedi4all.org/event/remedi4all-clinical-trials-webinar-rare-diseases/
LOCATION:Online Event
ATTACH;FMTTYPE=image/png:https://remedi4all.org/wp-content/uploads/2025/01/CT-Webinar-Series-Webinar-2-FINAL.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Amsterdam:20250221T110000
DTEND;TZID=Europe/Amsterdam:20250221T123000
DTSTAMP:20260422T021511
CREATED:20250121T164921Z
LAST-MODIFIED:20250124T135912Z
UID:9755-1740135600-1740141000@remedi4all.org
SUMMARY:REMEDi4ALL Clinical Trials Webinar Series: Introduction to Clinical Trials
DESCRIPTION:Register for Webinar 1 here!\n  \nMark your calendars for 11.00 – 12.30 CET on 21 February\, 28 February and 7 March as we take an early lunch to discuss clinical trials with REMEDi4ALL partners Beacon for Rare Diseases\, EURORDIS and ECRIN! \nEach session will build on the knowledge gained in the previous session – with session 1 acting as a beginners guide and session 3 involving a more in-depth look at who and what makes a clinical trial run successfully. \nWebinar 1: Introduction to Clinical Trials – 21 Feb (11:00-12:30 CET)\nWhy we do clinical research and what the process looks like for participants.\nThis webinar will explain why we do clinical research and what the process looks like for participants and answer some of the most common questions raised by trial participants and patients interested in clinical research. Find out more here. \nSee our other event listings to register for webinars 2 (rare diseases) and 3 (support and management of clinical trials).
URL:https://remedi4all.org/event/webinar-series-clinical-trials/
LOCATION:Online Event
ATTACH;FMTTYPE=image/png:https://remedi4all.org/wp-content/uploads/2025/01/CT-Webinar-Series-Webinar-1-v2.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Amsterdam:20250129T123000
DTEND;TZID=Europe/Amsterdam:20250129T133000
DTSTAMP:20260422T021511
CREATED:20241203T133709Z
LAST-MODIFIED:20241209T151131Z
UID:9127-1738153800-1738157400@remedi4all.org
SUMMARY:Webinar: Welcome to the REMEDi4ALL Digital Academy
DESCRIPTION:Are you ready to embark on an exciting digital learning journey with us? Join us on Wed Jan 29 2025 at 12:30 PM CET for our online event where we will introduce you to our innovative academy. \nDuring this event\, you will have the opportunity to learn about our cutting-edge digital courses\, interact with our experienced instructors\, and discover how REMEDi4ALL can help you enhance your skills and knowledge in drug repurposing. \nDon’t miss out on this chance to learn all about our repurposing curriculum and our upcoming events! Register now and get ready to take your drug repurposing knowledge to the next level with REMEDi4ALL Digital Academy. \nLearn more about the launch of the Digital Academy here.
URL:https://remedi4all.org/event/remedi4all-digital-academy-webinar/
LOCATION:Online Event
ATTACH;FMTTYPE=image/png:https://remedi4all.org/wp-content/uploads/2024/12/R4ALL-Digital-Academy-Webinar-Launch-SoMe-Card.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240622
DTEND;VALUE=DATE:20240626
DTSTAMP:20260422T021511
CREATED:20240516T134216Z
LAST-MODIFIED:20240516T134216Z
UID:6717-1719014400-1719359999@remedi4all.org
SUMMARY:ICCBH 2024 - 11th International Conference on Children’s Bone Health
DESCRIPTION:This conference will bring together scientists\, clinicians\, trainees\, allied health professionals and others from a wide range of disciplines to gain a better understanding of the growing skeleton in relation to childhood health and disease and to discuss the most recent developments in clinical outcomes\, novel therapies\, and genetic discoveries. The conference scope ranges from basic molecular mechanisms to clinical aspects\, from bone pathophysiology to prevention and medical and surgical treatment. \nThis conference is for anyone with an interest in bone metabolism and bone mass in children\, adolescents and young adults to attend. \nThe ICCBH conference takes place every two years. The 2022 meeting in Dublin was attended by over 400 participants from across the globe\, making it truly multinational and multidisciplinary. \nThe scientific programme is designed to present researchers\, physicians\, and allied health professionals with the newest research\, with sessions including plenary lectures by world-leading experts\, symposia\, workshops\, oral abstract communications\, poster sessions and meet the expert sessions. The conference will offer investigators from around the world an opportunity to meet with each other and with industry representatives. \nICCBH 2024 is your opportunity to hear about and discuss the newest developments in our understanding of paediatric bone health. \nLearn more and register here.
URL:https://remedi4all.org/event/iccbh-2024-11th-international-conference-on-childrens-bone-health/
LOCATION:Salzburg Congress\, Auerspergstraße 6\, 5020 Salzburg\, Austria\, Salzburg\, Austria
ATTACH;FMTTYPE=image/png:https://remedi4all.org/wp-content/uploads/2024/05/Event-Page-Image-R4A-169-ratio-2.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Amsterdam:20240613T083000
DTEND;TZID=Europe/Amsterdam:20240613T180000
DTSTAMP:20260422T021511
CREATED:20240321T143124Z
LAST-MODIFIED:20240524T124322Z
UID:5924-1718267400-1718301600@remedi4all.org
SUMMARY:2nd MULTI-STAKEHOLDER MEETING - Ensuring patient centricity in Osteogenesis Imperfecta research
DESCRIPTION:REMEDi4ALL is hosting our 2nd Multi-stakeholder Meeting (MS) – Ensuring patient centricity in Osteogenesis Imperfecta (OI) research.\n  \nJoin the MSM\nREMEDi4ALL invites all stakeholders in the OI research community to join us for a day of learning\, discussion\, and inspiration. \nWe welcome clinicians\, academics\, patients and patient representatives\, pharmaceutical companies\, regulators\, payers\, health economists and all interested in OI and Rare Bone Diseases research. Together\, we will discuss and develop patient centric approaches to research and medicines development for OI. \nOur MSM will: \n\nShare information and advance learning\, in a pre-competitive and cooperative setting\nDevelop constructive dialogue between all stakeholders\nFacilitate collaboration and knowledge exchange\nIdentify current hurdles and propose solutions to ensure patient centricity in OI research\nPublish and disseminate the meeting outcomes to a broader community\n\n The Power of Patients\nThe patient’s voice is at the heart of this meeting. The OI community and the REMEDi4ALL Patient Advocacy Group have played integral roles in shaping the content and format of this event. \nWe wanted to ensure that the patients’ perspectives\, experiences\, and preferences guide our discussions and are at the forefront of OI research and therapeutic development. Over the day\, you will hear from numerous patients\, patients representative and advocates. They will: \n\nShare their personal journeys of living with OI\, providing insights into the day-to-day challenges they face\, as well as the triumphs and setbacks they encounter.\nHighlight unmet medical needs within the OI community\nDiscuss patient-relevant research questions and identify research priorities\n\nPatients will have the opportunities to \n\nLearn about the recent advancements in medicines development in OI\nInitiate collaborations and partnerships with all stakeholders\nActively participate and engage in scientific discussions about OI\n\nPatient centricity will run as a core-narrative in all our sessions and panel discussions\, encouraging each stakeholder to consider the patient perspective in their current and future work. \nAgenda (might be subject to change)\nWEDNESDAY\, 12 JUNE 2024\n\n\n\n19.30/20.00\nArrival and Speakers Dinner at the Hotel\nBY INVITATION ONLY\n\n\n\n THURSDAY\, 13 JUNE 2024 (8.30 – 18.00 CEST)\n\n\n\n8.00 – 8.30\nRegistration\n \n\n\n8.30 – 8.40\nOpening Ceremony and Welcome\nClaudia Fuchs (EURORDIS) \nLeonardo Panzeri (AS.IT.O.I.) \nDonald Lo (EATRIS)\n\n\n\nOpening Speech\n\n\n\n8.40 – 9.00\nWhat does it mean living with OI?\nGem Turner\n\n\n\nSESSION 1: Multi-national strategies for Patient Advocacy in OI\nModerators: Claudia Fuchs\n\n\n\n9.00 – 9.10\nThe European Reference Network on rare bone diseases (ERN-Bond)\nLuca Sangiorgi (Istituto Ortopedico Rizzoli)\n\n\n9.10 – 9.20\nThe European Registries for Rare Bone and Mineral Conditions (EuRR-Bone)\nClaudia Finis (DOIG (German Ostogenesis Imperfecta Organisation) and Berlin Institute of Health at Charité)\n\n\n9.20 – 9.30\nPatient Engagement Initiatives in Rare Diseases: an Italian Perspective\nAnnalisa Scopinaro (UNIAMO – Federazione Italiana Malattie Rare)\n\n\n9.30 – 9.45\nQ/A session\n\n\n\nPANEL DISCUSSION – Ask the Expert: How to become a Patient Advocate in OI?\nModerators: Marina O’Callaghan & Claudia Fuchs\n\n\n\nLightning talks: European and National Patient Engagement Activities in OI\n\n\n10.00 – 10.05\nStronger Together: OIFE’s Patient Engagement Initiatives\nAnna Rossi (OIFE)\n\n\n10.05 – 10.10\nIntroduction to Patient Engagement Activities in Italy\nSimona Paveri (AS.IT.O.I.)\n\n\n10.10 – 10.15\nIntroduction to Patient Engagement Activities in Norway\nInger-Margrethe Stavdal Paulsen (Norsk Forening for Osteogenesis Imperfecta)\n\n\n10.15 – 10.20\nIntroduction to Patient Engagement Activities in Spain\nMiguel Rodríguez Molina (Asociación Nacional Huesos de Cristal OI España – AHUCE)\n\n\n10.20 – 10.25\nBrittle Bone Society – Support that matters most\nPatricia Osborne (Brittle Bone Society – BBS)\n\n\n10.25 – 11.00\nPanel Discussion – Ask the Expert: How to become a Patient Advocate in OI?Panelists: Gem Turner\, Annalisa Scopinaro\, Anna Rossi\, Miguel Rodríguez Molina\, Patricia Osborne\, Emilija and Dace Liepina\, Marie Holm Laursen \n\n\n\n11.00 – 11.30 Coffee Break \n SESSION 2: Initiatives in the OI community \nModerators: Anna Rossi & Luca Sangiorgi \n\n\n\n11.30 – 11.40\nThe Impact Survey Initiative\nOliver Semler (University of Cologne)\n\n\n11.40 – 11.50\nAdult Health Initiative\nStuart Ralson (University of Edinburgh)\n\n\n11.50 – 12.00\nCare4BrittleBones Initiative Key4OI\nLida Zhytnik (Amsterdam UMC)\n\n\n12.00 – 12.15\nQ/A session\n\n\n\n SESSION 3: Current Treatment Options in OI – a multistakeholder perspective\nModerators: Anna Rossi & Luca Sangiorgi \n\n\n\n12.20 – 12.40 \nIntroduction to different treatment options and approaches for OI\nNick Bishop (The University of Sheffield)\n\n\n\n12.40  – 14.00 Lunch Break \nCONTINUATION SESSION 3 \n\n\n\nLightning talks: Current ongoing clinical trials with specific focus on challenges and opportunities of Patient Engagement\n\n\n14.00 – 14.10 \nREMEDi4ALL MOI-A Study\nJudith Cohen (University of Hull)\n\n\n14.10 – 14.20\nTOPaZ trial\nStuart Ralson (University of Edinburgh)\n\n\n14.20 – 14.30\nThe ORBIT  Phase 2/3 study: a collaborative design to study outcomes in OI\nLuigi Picaro (Mereo BioPharma) \n\n\n14.30 – 14.40 \nBOOSTB4 Trial: Boost Brittle Bones Before Birth\nCecilia Götherström (Karolinska Institute)\n\n\n14.40 – 14.55 \nQ/A session\n\n\n\n SESSION 4:”Patient-centered clinical trial design”\nModerators: Nick Bishop & Claudia Fuchs \n\n\n\nLightining talks: Patient perception and experience in clinical trials\n\n\n15.00 – 15.10\nPatient Perspective as a Teenager\nEmilija and Dace Liepina\n\n\n15.10 – 15.20\nPatient Experience on the ASTEROID Trial\nMarie Holm Laursen\n\n\n15.20 – 15.30 \nPatient Engagement activites within the R4ALL demonstrator (MOI-A Study)\nMarina O’Callaghan\n\n\n15.30 – 15.45 \nQ/A session\n\n\n\n15.45– 16.15 Coffee Break \nPANEL DISCUSSION – Innovative outcome measures in clinical trials\nModerators: Inger-Margrethe Stavdal Paulsennger & Claudia Fuchs  \n\n\n\nLightning talks: Quality of Life assessment (QoL) and patient related innovative outcome measures in clinical trials in OI\n\n\n16.15 – 16.25\nQoL assessment in OI\nNick Bishop (The University of Sheffield)\n\n\n16.25 – 16.35 \nDeveloping patient related outcome measures on mobility in rare bone disorders\nLuca Sangiorgi (Istituto Ortopedico Rizzoli)\n\n\n16.35 – 16.45\nRegulatory perspective on innovative outcome measures – how can patients contribute?\nVioleta Stoyanova-Beninska (Committee for Orphan Medicinal Products)\n\n\n16.45 – 16.55 \nPatient perspective on innovative outcome measure – how to advocate?\nInger-Margrethe Stavdal Paulsen (Norsk Forening for Osteogenesis Imperfecta)\n\n\n17.00 – 17.40 \nPanel Discussion – innovative outcome measures in clinical trials  \nPanelists: Nick Bishop\, Stuart Ralson\, Luigi Picaro\, Cecilia Götherström\, Oliver Semmler\, Lida Zhytnik\, Violeta Stoyanova-Beninska\n\n\n\n\n\n\n17.40 – 17.50\nPatient engagement in early Health Technology Assessment (eHTA)\nZsuzsanna Petyko (Syreon Research Institute)\n\n\n17.50 – 18.00\nWrap Up and Closing Remarks\nClaudia Fuchs (EURORDIS)\n\n\n\n18.00 Get Together \n FRIDAY\, 14 JUNE 2024 \n9.00 – 11.00 CEST\n\n\n\n9.00 – 11.00\nWorkshop on early Health Technology Assessment (eHTA)\nBY INVITATION ONLY \nDalma Hosszu (Syreon Research Institute)\n\n\n\n*Please note that only meals (lunch\, coffee breaks and get-together) are covered by the event organisers. Participants need to arrange their own travel and accomodation. \n Download the programme here. \nDownload the event flier here. \nSpeakers\nClick here to see the complete list of speakers and their bios. \nConfirmed speakers: \n \n  \nOrganisers\nOrganised within the REMEDi4ALL project in collaboration with EURORDIS – Rare Disease Europe\, Beacon for Rare Diseases\, Associazione Italiana Osteogenesi Imperfetta – AS.IT.O.I.\, Osteogenesis Imperfecta Federation Europe – OIFE\, European Reference Network on rare bone diseases – ERN BOND. \n \n  \nRegistration\nThis event will be a hybrid event\, hosted both online and in-person (Bologna\, Italy). Registration closes on 31 May\, 2024. \nRegister here
URL:https://remedi4all.org/event/2nd-multi-stakeholder-meeting-ensuring-patient-centricity-in-osteogenesis-imperfecta-research/
LOCATION:Savoia Hotel Regency\, Via del Pilastro\, 2\, Bologna\, Italy
ATTACH;FMTTYPE=image/jpeg:https://remedi4all.org/wp-content/uploads/2024/03/Slide2.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20240508T090000
DTEND;TZID=America/Halifax:20240508T143000
DTSTAMP:20260422T021511
CREATED:20240319T091036Z
LAST-MODIFIED:20240319T091036Z
UID:5904-1715158800-1715178600@remedi4all.org
SUMMARY:Clinical Pharmacology Guidances Advancing Drug Development and Regulatory Assessment
DESCRIPTION:ABOUT THIS EVENT\nThis public workshop will be hosted by the FDA Office of Clinical Pharmacology (OCP) and the University of Maryland Center of Excellence in Regulatory Science and Innovation (M-CERSI). The purpose of this workshop is to serve as a mechanism to engage with the public to share information on existing clinical pharmacology guidances and identify emerging scientific topics that might benefit from the development of scientific research and recommendations. \nBACKGROUND\nAt every step of drug development\, clinical pharmacology is applied to generate\, evaluate\, and use knowledge of drug disposition\, pharmacology\, and disease biology to progressively reduce regulatory uncertainty and inform public health decision-making.   Clinical pharmacology principles form the basis of dosage selection and optimisation and promote therapeutic individualisation by translating the knowledge of patient diversity into clinical recommendations for safe and effective use of medications.   Therefore\, having clear\, pragmatic\, and contemporary scientific recommendations to inform drug development and regulatory assessment is critical for the successful and efficient development of therapeutics that protect and promote public health. Developing new or revising existing guidance documents\, especially in the broad field of clinical pharmacology\, requires a unique and integrated approach centered around multistakeholder partnerships. \nWORKSHOP GOALS\n\n\nProvide an overview of scientific recommendations pertaining to clinical pharmacology applications during drug development and regulatory assessment. \n\n\nDiscuss the current scientific challenges and gaps in applying clinical pharmacology principles during drug development. \n\n\nIdentify potential opportunities and priorities for regulatory research and scientific guidance development from a clinical pharmacology perspective. \n\n\nAGENDA\nClick here to see the full agenda. \nREGISTRATION\nRegistration is free.  All interested parties are encouraged to register early. Please click here to register. \n\nClick here to learn more.
URL:https://remedi4all.org/event/clinical-pharmacology-guidances-advancing-drug-development-and-regulatory-assessment/
LOCATION:Online & in-person (Maryland\, United States)\, MD\, United States
ATTACH;FMTTYPE=image/png:https://remedi4all.org/wp-content/uploads/2024/03/Event-Page-Image-R4A-169-ratio.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Amsterdam:20240307T151500
DTEND;TZID=Europe/Amsterdam:20240307T170000
DTSTAMP:20260422T021511
CREATED:20231129T132411Z
LAST-MODIFIED:20240227T174130Z
UID:4267-1709824500-1709830800@remedi4all.org
SUMMARY:REMEDi4ALL Funders Network Meeting
DESCRIPTION:iDR24 Satellite Event – REMEDi4ALL Funders Network Meeting\nAfter the iDR24 the members and observers of the REMEDi4ALL Funders Network will come together to discuss the next steps of the network\, including the strategic agenda. \nRegister here\nLocation: Recinte Modernista de Sant Pau. Green auditorium. \nThis will be a hybrid event – possible to join online. \nAGENDA
URL:https://remedi4all.org/event/idr24-satellite-event-funders-network-meeting/
LOCATION:Recinte Modernista de Sant Pau\, Calle St. Antoni Maria Claret\, 167\, Barcelona\, Spain
ATTACH;FMTTYPE=image/png:https://remedi4all.org/wp-content/uploads/2023/11/FUNDERS-NETWORK-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Amsterdam:20240306T080000
DTEND;TZID=Europe/Amsterdam:20240307T180000
DTSTAMP:20260422T021511
CREATED:20231130T141140Z
LAST-MODIFIED:20231130T141233Z
UID:4280-1709712000-1709834400@remedi4all.org
SUMMARY:REMEDi4ALL #iDR24 International Drug Repurposing Conference
DESCRIPTION:Please see this page for more information: https://remedi4all.org/international-drug-repurposing-conference/
URL:https://remedi4all.org/event/remedi4all-idr24-international-drug-repurposing-conference/
LOCATION:Recinte Modernista de Sant Pau\, Calle St. Antoni Maria Claret\, 167\, Barcelona\, Spain
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Amsterdam:20231114T090000
DTEND;TZID=Europe/Amsterdam:20231114T173000
DTSTAMP:20260422T021511
CREATED:20230915T105013Z
LAST-MODIFIED:20231016T150222Z
UID:3297-1699952400-1699983000@remedi4all.org
SUMMARY:REMEDi4ALL MULTI-STAKEHOLDER MEETING: Drug Repurposing\, an Attractive Strategy in Pancreatic Cancer Treatment?
DESCRIPTION:REMEDi4ALL is pleased to announce the first Multi-Stakeholder Meeting on drug repurposing in PANCREATIC CANCER. \nThis one-day in person workshop is aimed to bring together all relevant key stakeholders (patients and patient representatives\, academia\, industry\, regulators\, funders\, etc.) to discuss the recent state of art on drug repurposing in oncology and specifically in pancreatic cancer. Topics of discussion will include an overview of the disease and the current (preclinical and clinical) drug repurposing programs\, biomarkers\, the importance of a patient-centred outcome measures and patient engagement activities in the study design and implementation. In addition\, current hurdles including financial and regulatory barriers to successfully repurpose non-oncology drugs in pancreatic cancer will also be discussed. \nREGISTER HERE \nPreliminary Agenda (might be subject to change) \n\n\n\n8.30 – 9.00 \nWelcome and Registration \n\n\n9.00 – 9.10  \nOpen Ceremony  \nClaudia Fuchs  (REMEDi4ALL – EURORDIS) \n\n\n SESSION 1: SETTING THE SCENE  \nModerator: Claudia Fuchs (REMEDi4ALL – EURORDIS)  \n\n\n9.10 – 9.30  \nGeneral Introduction on Pancreatic Cancer \nAlfredo Carrato (Pancreatic Cancer Europe – PCE)  \n\n\n9.30 – 9.50 \nTackling pancreatic cancer: tricks and tips \nIlse Rooman (Anticancer Fund\, Vrije Universiteit Brussels) \n\n\n9.50 – 10.10  \nDrug repurposing in oncology – Attractive but not that simple \nGauthier Bouche  (REMEDi4ALL – Anticancer Fund) \n\n\n10.10– 10.25 \nREMEDi4ALL  (vision\, mission\, European Context) \nDonald Lo  (REMEDi4ALL – EATRIS) \n\n\n10.25 – 11.10 \nPatient Perspective on Drug Repurposing in Oncology \nPatrycja Rzadkowska (Pancreatic Cancer Europe – PCE and DiCE)   \nAli Stunt (Pancreatic Cancer Europe – PCE and Pancreatic Cancer Action UK)   \n\n\n COFFE BREAK 11.10 – 11.40 \n\n\n SESSION 2: TREATMENT OPTIONS AND DRUG REPURPOSING OPPORTUNITIES IN PANCREATIC CANCER   \nModerators: Gauthier Bouche/Patricia Vandamme (REMEDi4ALL – Anticancer Fund)  \n\n\n11.40 – 12.00 \nOrphan Medicinal Products for the Treatment of Pancreatic Cancer: Lessons Learned From Two Decades of Orphan Designation \nVioleta Stoyanova-Beninska (Medicines Evaluation Board\, Chair of Committee for Orphan Medicinal Products at EMA) \n\n\n12.00 – 12.20  \nPreclinical and Clinical Updates on Drug Repurposing Opportunities in Pancreatic Cancer \nLuca Cardone  (Istituto Nazionale Tumori Regina Elena and National Research Council of Italy)  \n\n\n12.20– 12.40 \nPatient Story  \nSteve Bigelsen  (Rutgers New Jersey Medical School\, Newark\, NJ\, USA) \n\n\n12.40 – 13.00  \nThe VESPA Trial – Repurposing valproic acid combined with simvastatin to potentiate first line gemcitabine/nab-paclitxel-chemotherapy regimen in metastatic pancreatic cancer patients \nAlfredo Budillon (REMEDi4ALL – Istituto Nazionale Tumori Fondazione Pascale)  \n  \n  \n\n\n LUNCH BREAK 13.00 – 14.00  \n\n\n SESSION 3: THE PAST\, PRESENT AND FUTURE OF PANCREATIC CANCER CLINICAL TRIALS  \nModerators: Eve Hewitt/Rick Thompson (REMEDi4ALL- Beacon)  \n\n\n14.00 – 14.40 \nFinancial and Regulatory Barriers and Potential Solutions  \n– Overview on the current findings within REMEDi4ALL and future perspectives \n– Industry perspective  \n– Funders persepective \nHeleen van der Meer (REMEDi4ALL – ZonMW)  \nRaluca Radu  (REMEDi4ALL – Medicines for Europe)  \nHans Platteeuw  (CEO Galenicap)  \nAlexandre Bento Costa Alencar  (Rising Tide Foundation) \n\n\n14.40 – 15.00 \nBiomarkers in Pancreatic Cancer \nMaría Laura Garcia Bermejo  (Ramon & Cajal Health Research Institute) \n\n\n15.00 – 15.20 \nPatient Centricity in Clinical Trials  \nAntonella Cardone  (Cancer Patients Europe – CPE)  \nFederica Valsecchi  (Fondazione Valsecchi) \n\n\n COFFE BREAK 15.20 – 15.50   \n\n\n  \n15.50 – 17.20  \n FINAL ROUNDTABLE AND DISCUSSION  \nModerators: Claudia Fuchs (REMEDi4ALL – EURORDIS) – Rick Thompson (REMEDi4ALL – Beacon) \n\n\n17.20 – 17.30    \nClosing Remarks   \nClaudia Fuchs (REMEDi4ALL – EURORDIS)  \nRick Thompson (REMEDi4ALL – Beacon) \n\n\n17.30 \nEnd of the Meeting  and “GET TOGETHER”  \n 
URL:https://remedi4all.org/event/remedi4all-multi-stakeholder-meeting/
LOCATION:Nhow Brussels Bloom\, Rue Royale 250\, 1210\, Brussels\, Belgium
ATTACH;FMTTYPE=image/png:https://remedi4all.org/wp-content/uploads/2023/09/Banner-1st-MSM_v2.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20230924
DTEND;VALUE=DATE:20230929
DTSTAMP:20260422T021511
CREATED:20230227T175823Z
LAST-MODIFIED:20230227T175823Z
UID:1884-1695513600-1695945599@remedi4all.org
SUMMARY:FIP Brisbane 2023: Pharmacy building a sustainable future for healthcare – Aligning goals to 2030
DESCRIPTION:81ST FIP WORLD CONGRESS OF PHARMACY AND PHARMACEUTICAL SCIENCES\nThe pharmacist is key in assuring a safe and effective supply of medicines as well as their responsible use. As a direct provider of services\, from primary prevention and screening of diseases\, immunisations to therapeutic monitoring\, the work of this profession ensures that a patient’s medical therapy is appropriate\, the most effective\, the safest possible and the most convenient. \nThe International Pharmaceutical Federation (FIP) Development Goals align pharmacists’ education with societal and healthcare needs\, taking into consideration the path to universal health coverage and the UN Sustainable Development Goals\, and make the case for investing in the pharmacy workforce of tomorrow. \nThese goals present the profession with the direction for advancement and transformation and establishing its place within the healthcare system. By linking the FIP vision with a needs-based pharmaceutical workforce transformation programme\, a sustainable future for healthcare can be built — aligning goals to 2030. \nLinked to a healthier world\, the “Pharmacy building a sustainable future for healthcare — aligning the goals” theme sets out long-term goals and principles\, as well as short-term actions\, to transform the role and contribution of pharmacy. That transformation is required to maximise the health gain that healthcare systems derive from their interactions with the pharmacy profession. \nLearn more and register for the congress here.
URL:https://remedi4all.org/event/fip-brisbane-2023-pharmacy-building-a-sustainable-future-for-healthcare-aligning-goals-to-2030/
LOCATION:Brisbane\, Australia
ATTACH;FMTTYPE=image/png:https://remedi4all.org/wp-content/uploads/2023/02/Event-Page-Image-R4A-169-ratio-8.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Amsterdam:20230705T120000
DTEND;TZID=Europe/Amsterdam:20230705T140000
DTSTAMP:20260422T021511
CREATED:20230609T130126Z
LAST-MODIFIED:20230907T122723Z
UID:2156-1688558400-1688565600@remedi4all.org
SUMMARY:Workshop - REMEDi4ALL: what’s in it for funders?
DESCRIPTION:Learn and discuss how REMEDi4ALL & the funders network can support your funding activities in drug repurposing \nTarget audience: Funders who are (willing to be) active in drug repurposing  \nWithin REMEDi4ALL an international funders network for drug repurposing is currently being created by ZonMw. So far\, more than 50 different funders from all over the world have expressed their interest to join the network. Many of them also already shared their experiences with and ideas of funding drug repurposing with us via an online survey and in face-to-face interviews. This is the first workshop where funders who are interested in joining the funders network come together. Within an interactive setting we will talk about how REMEDi4ALL and the funders network can support funders in drug repurposing. You will learn about current and upcoming activities in REMEDi4ALL related to funders. Also\, we will share and discuss the insights collected from funders on the barriers\, solutions and incentives needed for funding drug repurposing.  \nDOWNLOAD THE EVENT SUMMARY \nDOWNLOAD THE FULL PRESENTATION \n\n\nYour browser does not seem to support iframes. Click here to read this PDF.\n    Created using FlowPaper Flipbook Maker ↗\n                \n            \n  \nAgenda \n\n\n\nTime \nTopic \n\n\n12.00-12.05 \nWelcome  \nChair: Heleen van der Meer (ZonMw) \n\n\n12.05-12.30 \nIntroduction REMEDi4ALL and funders network  \nAnton Ussi (EATRIS) & Heleen van der Meer (ZonMw) \n\n\n12.30-12.40 \nHow do you repurpose? REMEDi4ALL’s training programme for the whole repurposing ecosystem  \nRick Thomson (BEACON: for rare diseases) \n+ input from all participants \n\n\n  \n12.40-12.50 \nIntroduction to the REMEDi4ALL Funding Decision Tool  \nMarcell Csanadi (Syreon Research Institute)  \n+ input from all participants \n\n\n12.50-13.00 \nQ&A – break \n\n\n13.00-13.20 \nFunding drug repurposing: barriers\, solutions & incentives needed  \nHeleen van der Meer (ZonMw) \n\n\n13.20-13.45 \nPaneldiscussion  \nModerated by Pan Pantziarka (Anticancer Fund)  \nPanellists:  \n\nJoanna Davidge (LifeArc) \nTeun Grooters (Arega Medical) \nSagair Hussain (DEBRA) \nSarah Puddicombe (National Institute for Health and Care Research Coordinating Centre (NIHR CC)) \n\n\n\n\n13.45-14.00 \nNext steps for the funders network & closing  \nHeleen van der Meer (ZonMw)  \n+ input from all participants \n\n\n\n 
URL:https://remedi4all.org/event/workshop-remedi4all-whats-in-it-for-funders/
LOCATION:Online Event
ATTACH;FMTTYPE=image/png:https://remedi4all.org/wp-content/uploads/2023/06/R4A-3-002.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Amsterdam:20230628T100000
DTEND;TZID=Europe/Amsterdam:20230711T120000
DTSTAMP:20260422T021511
CREATED:20230608T080135Z
LAST-MODIFIED:20230614T091303Z
UID:2151-1687946400-1689076800@remedi4all.org
SUMMARY:Creating Health Impact from Research: Course of 3 Live Sessions
DESCRIPTION:If you are an Early Career Researcher who aims to enhance your skills to make an impact in healthcare research\, this course is for perfect you! \nSupported by the Wellcome Trust Institutional Translational Partnership Award (iTPA)\, we are working with UCL Academic Careers Office to sponsor UCL participants for this online course\, with the course fee fully covered. Register now to secure your spot as there is a limited quota available on a first-come-first-served basis. \nAbout this course\nThis course offers professional commercialization training for Higher Education Institutions across the UK. It consists of a series of live sessions accompanied by learning videos created by Pete Moores. \nIn this course\, you will: \n\nDevelop an impact hypothesis for your work\nDevelop your route to impact skills in three live\, online workshops\nGet practical support through an online community\n\n\nAbout the trainer\nPete is a consultant\, mentor\, coach and trainer in the translational field with a vast experience in working at the intersection of science and technology\, industry application and funding. He’s driven by a passion to create real-world benefits from new science and technology. \nHe has previously worked as a head coach on international training and mentoring programmes and has mentored\, coached\, and trained global researchers and entrepreneurs to develop strategic sales and marketing initiatives that unlock their innovation potential. \n\nLive Session Programme\n\nWednesday 28 June 2023\, 10:00-12:00\nBuilding a Bridge to the Market: the foundations of commercialisation\nWednesday 5 July 2023\, 10:00-12:00\nHow to Write a Successful Translational Research Application\nTuesday 11 July 2023\, 10:00-12:00\nCreating impact from scientific research\n\n\nWho is this course for?\nWe encourage Early Career Researchers (e.g. post-docs\, fellows and newly established lecturers) with an interest in delivering impact in healthcare research to sign up\, but this course is also open to any researcher who has not previously had translational-type project funding independent of their career stage. This course is NOT suitable for PhD or MRes students. If you have not engaged in any previous translational activity\, but are keen to do so\, this is the course for you! \n\nCourse Delivery\nThis workshop has been arranged by the University of Birmingham Translational Research Team\, together with a network of other Universities\, each supported by a Wellcome Trust Institutional Translational Partnership Award (iTPA). This event is part of an ongoing effort to support researchers in translating ground-breaking discovery research findings into practical improvements in human health. \nUCL participants will join the training sessions alongside researchers from the University of Birmingham\, and everyone will be encouraged to ask questions and network with fellow attendees. \n  \nLearn more and register here.
URL:https://remedi4all.org/event/creating-health-impact-from-research-course-of-3-live-sessions/
LOCATION:Online Event
ATTACH;FMTTYPE=image/png:https://remedi4all.org/wp-content/uploads/2023/06/Event-Page-Image-R4A-169-ratio.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20230619
DTEND;VALUE=DATE:20230624
DTSTAMP:20260422T021511
CREATED:20221018T143020Z
LAST-MODIFIED:20221018T143020Z
UID:558-1687132800-1687564799@remedi4all.org
SUMMARY:Open Academy Schools 2023
DESCRIPTION:The Open Academy School on Medicines Research & Development is a training programme offered by\nEURORDIS\, designed to help participants become experts in medicines research and development. \nThe 2023 edition of the Open Academy Schools will take place in-person from 19-23 June in Barcelona. Schools are delivered in English in a blended format\, comprising e-learning modules\, pre-training webinars and face-to-face intensive days. Following a review of our training offerings\, we are excited to announce a new format for our in-person training. \nFrom 2023\, the face-to-face intensive week of the Open Academy School on Medicines Research & Development (formerly EURORDIS Summer School) and the Open Academy School on Scientific Innovation & Translational Research (formerly EURORDIS Winter School) will take place during the same week\, incorporating three days of parallel sessions and two days of joint sessions focusing on patient engagement across the whole life-cycle of a medicine. Greater knowledge sharing and networking opportunities will be fostered with both sets of trainees together during the week. \nThe new format will include off-site visits to research facilities\, greater contact time with faculty and EURORDIS staff and the chance to network with fellow patient advocates\, supporting each other in learning and practice during the training and beyond. \nClick here to learn more and to submit your application. The deadline for sending applications is on October 24.
URL:https://remedi4all.org/event/open-academy-schools-2023/
LOCATION:Barcelona
ATTACH;FMTTYPE=image/png:https://remedi4all.org/wp-content/uploads/2022/10/Open-Academy-Banner.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Amsterdam:20230512T133000
DTEND;TZID=Europe/Amsterdam:20230512T181500
DTSTAMP:20260422T021511
CREATED:20230512T091101Z
LAST-MODIFIED:20230512T091101Z
UID:2071-1683898200-1683915300@remedi4all.org
SUMMARY:Personalized Health Series - Workshop on Drug Repurposing
DESCRIPTION:The goal of this workshop series is to foster and strengthen partnerships and collaborations between industry and universities\, and to define a few pilot projects that are leading to innovation and societal impact. \nThis year’s edition will focus on Drug Repurposing. As in previous workshops\, the goal is to engage professionals from both academia and the pharma sector\, showing their joint initiatives with the aim to inspire new potential partnerships\, and to spark interdisciplinary and cross-functional interests. \nThe presentation of these join initiatives will be followed by the panel discussion “Harnessing the power of collaborations and partnerships”\, which will explore how to facilitate and accelerate partnerships and collaborations between academia and industry\, as well as how to remove obstacles to pave the way into impactful progess. \nAGENDA\n13:30 – 13:45 Welcome \n\nDr. Bram Stieltjes\, Head of Department Research & Analysis Services\, University Hospital\nBasel\, Chair of Personalized Health Basel\nDr. Raffaello Ferone\, Research Coordinator at Personalized Health Basel\nDr. Alessandro Mazzetti\, Team Lead\, Innovation Collaborations at Innovation Office\n\nCollaborations between Pharma companies and Academia \n13:45 – 14:10 Genome-assisted drug repurposing in psychiatry \n\nProf. Andreas Papassotiropulos\, University of Basel\n\n14:10 – 14:35 Combining Protein & Ligand Centric approaches to predict Drug Repurposing with in-silico\nPolypharmacology \n\nDr. Andrea Beccari\, Dompé farmaceutici S.p.A.\n\n14:35 – 15:00 REMEDi4ALL – the European platform for medicines repurposing & REMEDi4ALL Funders Network \n\nDr. Heleen van der Meer\, ZonMw\, and Dr. Anton Ussi\, EATRIS\n\n15:00 – 15:20 Break \n15:20 – 15:50 Pitching session \n\nSmall Molecules\, Big Opportunities: A Multi-Purpose Platform for Off-Target Analysis\nProf. Martin Smiesko\, University of Basel\nUsing implementation science to power the research pipeline towards faster transla-\ntion in real-world settings\nDr. Sabine Valenta\, Institute for Nursing Science\nHolistic Approach to Personalized Medicine & Host-Response Monitoring: Quantifying Pro-\ntein & Nucleic Acid Biomarkers with Diaxxo’s Desktop qPCR Platform\nEngr. Joseph Iwasyk\, Swiss TPH\nDrug repurposing for helminth infections\nProf. Jennifer Keiser\, Swiss TPH\nPicky Binders: choose the right predictor for your drug or target\nDr. Janani Durairaj\, University of Basel\n\n  \n15:50 – 17:10 Panel discussion: Harnessing the power of collaborations and partnerships: What is still needed in Drug Repurposing? From in-silico discoveries to business models – How to\nremove obstacles and facilitate and accelerate partnerships and collaborations? \nPanelists: Prof. Henriette Meyer zu Schwabedissen (University of Basel)\, Charlotte Piens\n(STADA Arzneimittel AG)\, Dr. Andrea Beccari\, (Dompé farmaceutici S.p.A.)\, Engr. Silvano\nColetti (CEO Chelonia Applied Science) Moderator: Dr. Benjamin Kasenda (Senior Consul-\ntant Medical Oncologist\, University Hospital Basel) \n17:10 – 18:15 Networking Apéro \n  \nOrganising Team:\n\nRaffaello Ferone (Personalized Health Basel) – raffaello.ferone@unibas.ch\nAlessandro Mazzetti (Innovation Office) – alessandro.mazzetti@unibas.ch
URL:https://remedi4all.org/event/personalized-health-series-workshop-on-drug-repurposing/
LOCATION:Innovation Office Garage\, Kreuzstrasse 4\, Allschwil
ATTACH;FMTTYPE=image/png:https://remedi4all.org/wp-content/uploads/2023/05/Event-Page-Image-R4A-169-ratio.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20230322
DTEND;VALUE=DATE:20230325
DTSTAMP:20260422T021511
CREATED:20230317T081242Z
LAST-MODIFIED:20230317T081242Z
UID:1920-1679443200-1679702399@remedi4all.org
SUMMARY:DIA Europe 2023
DESCRIPTION:DIA EUROPE is the largest neutral event in the European life science industry – the knowledge hub between science\, healthcare\, and regulation. For it’s 35th anniversary\, DIA Europe is back in Basel\, where all thought leaders meet in person to discuss\, inspire\, and network. \nDIA Europe 2023 is designed to drive insights into action by connecting key policy discussions to real-world knowledge. Gathering innovative thought leaders from the entire life science landscape\, DIA will have 4 new content tracks in 2023: \n\nArtificial Intelligence and Data Science\nEU Health Policy and Regulatory Strategy\nMedical Devices and Combination Products\nProfessional Development\n\nLearn more about DIA EUROPE 2023 here.
URL:https://remedi4all.org/event/dia-europe-2023/
LOCATION:Basel\, Switzerland
ATTACH;FMTTYPE=image/png:https://remedi4all.org/wp-content/uploads/2023/03/Event-Page-Image-R4A-169-ratio.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20230228
DTEND;VALUE=DATE:20230301
DTSTAMP:20260422T021511
CREATED:20230111T130858Z
LAST-MODIFIED:20230111T130858Z
UID:1026-1677542400-1677628799@remedi4all.org
SUMMARY:Rare Disease Day 2023
DESCRIPTION:Rare Disease Day – observed on the last day of February – aims to raise awareness for those living with a rare disease and their families and carers\, as well as help improve therapeutic options and access to treatments. \nAbout 3.5-5.9% of the world population (around 260-440 million people) is living with a rare disease. Those affected with a rare disease face specific challenges. Initial misdiagnosis and delay in diagnosis are common due to lack of scientific knowledge and varying symptoms between patients with the same rare disease. Additionally\, those living with a rare disease face difficulties in accessing quality treatments and care. \nREMEDi4ALL pursues the exploration of using existing medicines to address areas of unmet medical needs\, including the research of innovative repurposed medicines for targeted rare diseases.
URL:https://remedi4all.org/event/rare-disease-day-2023/
ATTACH;FMTTYPE=image/png:https://remedi4all.org/wp-content/uploads/2023/01/Event-Page-Image-R4A-169-ratio-2.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Asia/Tokyo:20230220T100000
DTEND;TZID=Asia/Tokyo:20230220T183000
DTSTAMP:20260422T021511
CREATED:20230110T102031Z
LAST-MODIFIED:20230110T102031Z
UID:994-1676887200-1676917800@remedi4all.org
SUMMARY:3rd PSTC Japan Safety Biomarker Workshop
DESCRIPTION:C-Path’s Predictive Safety Testing Consortium will be hosting its 3rd PSTC Japan Safety Biomarker Workshop on February 20\, 2023 in Fujisawa\, Japan. \nThe utilization of biomarkers in guiding drug development decisions through clinical trials and post marketing studies is increasing. This conference will explore the areas of cooperation in the clinical application of biomarkers and drug development tools and their qualification and share knowledge about safety biomarkers in drug development via speaker presentations and panel discussions. Representatives from academia\, government and industry will participate. The workshop is co-sponsored by The Japan Society of Toxicology. \nLearn more and register for the workshop here.
URL:https://remedi4all.org/event/3rd-pstc-japan-safety-biomarker-workshop/
LOCATION:Fujisawa\, Japan\, SHONAN HEALTH INNOVATION PARK 26-1\, Muraoka-Higashi 2-chome\, Fujisawa\, Kanagawa\, 251-8555\, Japan
ATTACH;FMTTYPE=image/png:https://remedi4all.org/wp-content/uploads/2023/01/Event-Page-Image-R4A-169-ratio-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Amsterdam:20230208T140000
DTEND;TZID=Europe/Amsterdam:20230208T153000
DTSTAMP:20260422T021511
CREATED:20230118T165249Z
LAST-MODIFIED:20230118T165249Z
UID:1202-1675864800-1675870200@remedi4all.org
SUMMARY:Webinar: Getting Started with Medicines Repurposing
DESCRIPTION:BEACON has partnered with LifeArc to help patient group leaders and academics team up to begin repurposing research on their specific rare condition. \nJoin us for a 3-part educational series that progresses through the drug repurposing journey using LifeArc’s newly developed Drug Repurposing toolkit that’s been designed with patient groups and academics in mind! \nIt takes a village to bring a licensed treatment to market\, especially when developing it from scratch. Drug repurposing provides hope. \nRegister now to learn how to navigate the drug repurposing landscape and bring a repurposed therapy to market! \nDates of 3-part educational series: 8th February\, 22nd February\, 8th March \nPlease note: This educational series is for leaders of rare disease patient groups and those within them that have a medical/scientific interest in drug development and repurposing. Academics who are thinking of getting involved in rare repurposing and research are highly encouraged to attend this series\, as it’s been designed specifically to benefit you!
URL:https://remedi4all.org/event/webinar-getting-started-with-medicines-repurposing/
ATTACH;FMTTYPE=image/png:https://remedi4all.org/wp-content/uploads/2023/01/Event-Page-Image-R4A-169-ratio-3.png
END:VEVENT
END:VCALENDAR